These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15316565)

  • 1. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
    Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
    Cancer Res; 2004 Jun; 64(11):3987-93. PubMed ID: 15173012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
    Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
    Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 Apr; 317(1):133-41. PubMed ID: 15047158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    Biochem Biophys Res Commun; 2004 May; 317(3):837-43. PubMed ID: 15081416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer.
    Chen J; Li Q; An Y; Lv N; Xue X; Wei J; Jiang K; Wu J; Gao W; Qian Z; Dai C; Xu Z; Miao Y
    Int J Oncol; 2013 Sep; 43(3):877-85. PubMed ID: 23857344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Ashley SW; Whang EE
    J Biol Chem; 2004 May; 279(22):23176-82. PubMed ID: 15047698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
    Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
    J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
    Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
    Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29a suppresses the growth, migration, and invasion of lung adenocarcinoma cells by targeting carcinoembryonic antigen-related cell adhesion molecule 6.
    Han HS; Son SM; Yun J; Jo YN; Lee OJ
    FEBS Lett; 2014 Oct; 588(20):3744-50. PubMed ID: 25171863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
    Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
    Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
    Deng X; Liu P; Zhao Y; Wang Q
    Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells.
    Cheng TM; Murad YM; Chang CC; Yang MC; Baral TN; Cowan A; Tseng SH; Wong A; Mackenzie R; Shieh DB; Zhang J
    Eur J Cancer; 2014 Mar; 50(4):713-21. PubMed ID: 22918079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
    Liau SS; Jazag A; Whang EE
    Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
    Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
    Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Feb; 23(7):1448-56. PubMed ID: 14973554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.